Updated: May 1 2021, 1:16 ET
Invalid Date,
THE US State Department has advised Americans against traveling to India as Covid-19 cases continue to surge in the country as Biden bans travel from next week.
In a statement released Wednesday, the U.S. Embassy in India advised Americans to fly back to the U.S. when it’s safe to do so.
4
Both the U.S. State Department the Centers for Disease Control and Prevention (CDC) issued a Level 4 of travel advisoryCredit: Getty
The U.S. Embassy added that daily direct flights to the U.S. and flights via Paris and Frankfurt are available to bring Americans back home.
HERE WE CO AGAIN?
China hit by first cases of Indian double mutant Covid sparking fears of bug spreading like wildfire AGAIN
13:08 ET, Apr 30 2021
CHINA has reported its first cases of the “double mutant” coronavirus variant first discovered in India - sparking fears of a resurgence of the bug.
Health authorities are on high alert after the highly transmissible new strain was detected in a number of Chinese cities.
3
3
The B.1.617 strain, which contains two mutations of potential concern, has been ripping through India in the past month and fuelled a surge in hospitalisations and deathsCredit: AP
The B.1.617 strain, which contains two mutations of potential concern, has been ripping through India in the past month and fuelled a surge in hospitalisations and deaths.
New York City is moving to fully reopen on July 1, Mayor Bill de Blasio said, though Governor Andrew Cuomo said he wants it to happen sooner. Chicago is broadly easing restrictions to allow for higher capacity at restaurants, bars and large indoor venues. Michigan will tie reopening to hitting vaccination benchmarks.
A surge in Oregon is sweeping through a partially vaccinated population, with steep rises in case rates among the young – an indication that the US may struggle with distinct outbreaks for months to come. Meanwhile, the country’s focus on increasing vaccine supply for other nations may mean boosting manufacturing at US facilities rather than waiving intellectual-property protections, the White House said.
Author of the article: GlobeNewswire
Publishing date: Apr 27, 2021  â¢Â 51 minutes ago  â¢Â 4 minute read  â¢Â
Article content
Generex receives $2 million payment from Chinese partners to provide research results, data, and necessary documents to support an IND submission to the Chinese National Medical Products Administration (NMPA)
MIRAMAR, Fla., April 27, 2021 (GLOBE NEWSWIRE) â Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that in connection with its partnership with the National Institute for Viral Disease Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing Youfeng International Consulting Co., Ltd and Beijing Guoxin Haixiang Equity Investment Partnership, the company has received a $2 million development payment from Beijing Youfeng Biological Technology, Ltd (Youfeng-BI). In exchange for this payment, Generex will provide
Ethical Approval
The study was approved by the KSUMC Institutional Review Board, reference number (Ref. No. 20/0497/IRB). This study was conducted in accordance with the Declaration of Helsinki. Patient consent to review their medical records was not required by the KSUMC Institutional Review Board due to the anonymized data collection and maintained with confidentiality.
Statistical Analysis
All statistical analyses were performed using the Statistical Package for the Social Sciences software, version 22.0 (SPSS Inc., Chicago, IL, USA). Continuous variables were presented as the means ± standard deviations (SDs) and compared using one-way ANOVA to test the difference between variables and three groups of FRS. The categorical data were presented as numbers and percentages (%) and compared using the Chi-square test to determine whether there are significant differences between variables and three levels of FRS. Multiple logistic regression analysis was used to examine the associat